Saiyu Soka Hospital   Report issue

Academic/Hospital Phase 3
Founded: Sōka Japan (1988)

Organization Overview

First Clinical Trial
2019
NCT03873116
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Saiyu Soka Hospital

Active Ingredients

Drugs in Phase 3 Trials (1)

berotralstat (Orladeyo) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Angioedema (Phase 3)

Angioedemas, Hereditary (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1